Trial intelligence / Profile preview

SWOG S0701 H. pylori Eradication Trial

NCT01061437Phase 3Completed

Sponsor
SWOG Cancer Research Network
Start
Jun 2009
Primary completion
Jul 2011
Modality
Small Molecules
Countries
6
01

Overview

A Phase 3 trial of lansoprazole, amoxicillin, clarithromycin, metronidazole in Helicobacter pylori infection, sponsored by SWOG Cancer Research Network. Started Jun 2009; status: completed.

02

Drugs

lansoprazoleamoxicillinclarithromycinmetronidazole
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT01061437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01061437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call